Central amygdala micro-circuits mediate fear extinction.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 07 2021
Historique:
received: 02 07 2020
accepted: 28 05 2021
entrez: 7 7 2021
pubmed: 8 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Fear extinction is an adaptive process whereby defensive responses are attenuated following repeated experience of prior fear-related stimuli without harm. The formation of extinction memories involves interactions between various corticolimbic structures, resulting in reduced central amygdala (CEA) output. Recent studies show, however, the CEA is not merely an output relay of fear responses but contains multiple neuronal subpopulations that interact to calibrate levels of fear responding. Here, by integrating behavioural, in vivo electrophysiological, anatomical and optogenetic approaches in mice we demonstrate that fear extinction produces reversible, stimulus- and context-specific changes in neuronal responses to conditioned stimuli in functionally and genetically defined cell types in the lateral (CEl) and medial (CEm) CEA. Moreover, we show these alterations are absent when extinction is deficient and that selective silencing of protein kinase C delta-expressing (PKCδ) CEl neurons impairs fear extinction. Our findings identify CEA inhibitory microcircuits that act as critical elements within the brain networks mediating fear extinction.

Identifiants

pubmed: 34230461
doi: 10.1038/s41467-021-24068-x
pii: 10.1038/s41467-021-24068-x
pmc: PMC8260764
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4156

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH122561
Pays : United States

Références

Science. 2005 Apr 8;308(5719):245-8
pubmed: 15821089
Nature. 2008 Jul 31;454(7204):642-5
pubmed: 18615014
Nat Neurosci. 2015 Oct;18(10):1493-500
pubmed: 26322928
Nat Neurosci. 2010 Apr;13(4):489-94
pubmed: 20208529
Neuron. 2014 Jan 22;81(2):428-37
pubmed: 24462103
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):
pubmed: 31988201
Nature. 2015 Mar 26;519(7544):455-9
pubmed: 25600269
Curr Opin Neurobiol. 2018 Apr;49:141-147
pubmed: 29522976
Neuropharmacology. 2013 Jan;64:414-23
pubmed: 22722028
Exp Mol Med. 2018 Apr 9;50(4):1-16
pubmed: 29628509
J Neurosci. 2008 Aug 6;28(32):8074-85
pubmed: 18685032
J Comp Physiol Psychol. 1969 Mar;67(3):370-5
pubmed: 5787388
Learn Mem. 2004 Nov-Dec;11(6):770-86
pubmed: 15537742
J Neurophysiol. 2004 Jul;92(1):1-9
pubmed: 15212433
Nat Rev Neurosci. 2015 Jun;16(6):317-31
pubmed: 25991441
Nature. 2017 Feb 2;542(7639):96-100
pubmed: 28117439
Cell Rep. 2017 Nov 14;21(7):1770-1782
pubmed: 29141212
Hippocampus. 2012 May;22(5):1096-106
pubmed: 21618640
Eur J Neurosci. 2010 Feb;31(4):599-612
pubmed: 20384807
Nature. 2010 Nov 11;468(7321):277-82
pubmed: 21068837
Physiology (Bethesda). 2015 Sep;30(5):389-401
pubmed: 26328883
Br J Pharmacol. 2014 Oct;171(20):4690-718
pubmed: 24835117
Nat Commun. 2020 Jan 22;11(1):422
pubmed: 31969571
Biol Psychiatry. 2002 Nov 15;52(10):976-86
pubmed: 12437938
J Neurosci. 2007 Jan 17;27(3):684-91
pubmed: 17234600
Mol Psychiatry. 2007 Feb;12(2):120-50
pubmed: 17160066
Nat Neurosci. 2019 Dec;22(12):2000-2012
pubmed: 31712775
Neuropsychopharmacology. 2012 May;37(6):1534-47
pubmed: 22334122
Biol Psychiatry. 2006 Aug 15;60(4):352-60
pubmed: 16616731
J Neurosci. 2016 Jun 15;36(24):6488-96
pubmed: 27307236
J Neurosci. 2006 May 24;26(21):5733-8
pubmed: 16723530
Neuron. 2011 Jun 9;70(5):830-45
pubmed: 21658578
Nature. 2008 Jul 31;454(7204):600-6
pubmed: 18615015
Nat Neurosci. 2013 Mar;16(3):332-9
pubmed: 23354330
Psychopharmacology (Berl). 2019 Jan;236(1):21-32
pubmed: 30377749
Nature. 2016 Jun 01;534(7606):206-12
pubmed: 27279213
Behav Res Ther. 1988;26(2):137-49
pubmed: 3365204
J Neurosci. 2010 Oct 13;30(41):13586-96
pubmed: 20943900
J Neurosci. 2001 Mar 1;21(5):1720-6
pubmed: 11222661
J Neurosci. 2011 Jan 5;31(1):289-94
pubmed: 21209214
Nat Neurosci. 2017 Dec;20(12):1680-1685
pubmed: 29184202
Psychopharmacology (Berl). 2019 Jan;236(1):339-354
pubmed: 30302511
Cell. 2016 Nov 3;167(4):961-972.e16
pubmed: 27773481
Annu Rev Neurosci. 2000;23:155-84
pubmed: 10845062
Neuroscience. 2005;132(4):943-53
pubmed: 15857700
Nature. 2014 May 22;509(7501):453-8
pubmed: 24814341
J Neurosci. 2014 Feb 12;34(7):2432-7
pubmed: 24523533
Nature. 2010 Nov 11;468(7321):270-6
pubmed: 21068836
Neuroscience. 1993 Dec;57(4):1077-90
pubmed: 8309544

Auteurs

Nigel Whittle (N)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI, University of Innsbruck, Innsbruck, Austria.

Jonathan Fadok (J)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Department of Psychology and Tulane Brain Institute, Tulane University, New Orleans, LA, USA.

Kathryn P MacPherson (KP)

Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA.

Robin Nguyen (R)

Laboratory of Systems Neuroscience, Department of Physiology, University of Bern, Bern, Switzerland.

Paolo Botta (P)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Zuckerman Institute, Columbia University, New York, NY, USA.

Steffen B E Wolff (SBE)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.

Christian Müller (C)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.

Cyril Herry (C)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
INSERM, Neurocentre Magendie, U1215, Bordeaux, France.

Philip Tovote (P)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.

Andrew Holmes (A)

Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, USA.

Nicolas Singewald (N)

Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI, University of Innsbruck, Innsbruck, Austria.

Andreas Lüthi (A)

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. andreas.luthi@fmi.ch.
University of Basel, Basel, Switzerland. andreas.luthi@fmi.ch.

Stéphane Ciocchi (S)

Laboratory of Systems Neuroscience, Department of Physiology, University of Bern, Bern, Switzerland. stephane.ciocchi@pyl.unibe.ch.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH